{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:04:23Z","timestamp":1740107063863,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2020QH1079"],"award-info":[{"award-number":["2020QH1079"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870135","U2005204","82000142"],"award-info":[{"award-number":["81870135","U2005204","82000142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program","doi-asserted-by":"crossref","award":["2021-76"],"award-info":[{"award-number":["2021-76"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Provincial Clinical Research Center for Hematological Malignancies","award":["2020Y2006"],"award-info":[{"award-number":["2020Y2006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00432-022-04381-8","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T10:02:57Z","timestamp":1665482577000},"page":"2311-2318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era"],"prefix":"10.1007","volume":"149","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lushan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4438-2544","authenticated-orcid":false,"given":"Jianda","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"4381_CR1","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36(7):1720\u20131748","DOI":"10.1038\/s41375-022-01620-2"},{"issue":"5","key":"4381_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/bjh.14831","volume":"178","author":"S Alonso-\u00c1lvarez","year":"2017","unstructured":"Alonso-\u00c1lvarez S, Magnano L, Alcoceba M et al (2017) Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group. Br J Haematol 178(5):699\u2013708","journal-title":"Br J Haematol"},{"issue":"7","key":"4381_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1023\/A:1008265532487","volume":"9","author":"JR Anderson","year":"1998","unstructured":"Anderson JR, Armitage JO, Weisenburger DD (1998) Non-Hodgkin\u2019s lymphoma classification project. Epidemiology of the non-hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol 9(7):717\u2013720","journal-title":"Ann Oncol"},{"issue":"3","key":"4381_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/hon.2711","volume":"38","author":"J Apostolidis","year":"2020","unstructured":"Apostolidis J, Mokhtar N, Al Omari R et al (2020) Follicular lymphoma: update on management and emerging therapies at the dawn of the new decade. Hematol Oncol 38(3):213\u2013222","journal-title":"Hematol Oncol"},{"issue":"4","key":"4381_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.hoc.2020.03.001","volume":"34","author":"C Casulo","year":"2020","unstructured":"Casulo C (2020) Treatment of histologic transformation. Hematol Oncol Clin North Am 34(4):785\u2013794","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"4381_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.hoc.2020.02.001","volume":"34","author":"JR Cerhan","year":"2020","unstructured":"Cerhan JR (2020) Epidemiology of Follicular Lymphoma. Hematol Oncol Clin North Am 34(4):631\u2013646","journal-title":"Hematol Oncol Clin North Am"},{"issue":"27","key":"4381_CR7","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncol"},{"issue":"2","key":"4381_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1365-2141.2012.09054.x","volume":"157","author":"A Conconi","year":"2012","unstructured":"Conconi A, Ponzio C, Lobetti-Bodoni C et al (2012) Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br J Haemato 157(2):188\u2013196","journal-title":"Br J Haemato"},{"issue":"3","key":"4381_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","volume":"32","author":"M Dreyling","year":"2021","unstructured":"Dreyling M, Ghielmini M, Rule S et al (2021) Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(3):298\u2013308","journal-title":"Ann Oncol"},{"issue":"33","key":"4381_CR10","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1200\/JCO.2006.07.5671","volume":"24","author":"H Ghesqui\u00e8res","year":"2006","unstructured":"Ghesqui\u00e8res H, Berger F, Felman P et al (2006) Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis. J Clin Oncol 24(33):5234\u20135241","journal-title":"J Clin Oncol"},{"issue":"6","key":"4381_CR11","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1182\/blood-2002-07-2298","volume":"101","author":"CP Hans","year":"2003","unstructured":"Hans CP, Weisenburger DD, Vose JM et al (2003) A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood 101(6):2363\u20132367","journal-title":"Blood"},{"issue":"3","key":"4381_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/leu.2014.251","volume":"29","author":"HR Junl\u00e9n","year":"2015","unstructured":"Junl\u00e9n HR, Peterson S, Kimby E et al (2015) Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study. Leukemia 29(3):668\u2013676","journal-title":"Leukemia"},{"issue":"17","key":"4381_CR13","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood-2015-11-624288","volume":"127","author":"BS Kahl","year":"2016","unstructured":"Kahl BS, Yang DT (2016) Follicular lymphoma: evolving therapeutic strategies. Blood 127(17):2055\u20132063","journal-title":"Blood"},{"issue":"7","key":"4381_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/annonc\/mdw185","volume":"27","author":"K Koch","year":"2016","unstructured":"Koch K, Hoster E, Ziepert M et al (2016) Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Ann Oncol 27(7):1323\u20131329","journal-title":"Ann Oncol"},{"issue":"18","key":"4381_CR15","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","volume":"126","author":"R Kridel","year":"2015","unstructured":"Kridel R, Mottok A, Farinha P et al (2015) Cell of origin of transformed follicular lymphoma. Blood 126(18):2118\u20132127","journal-title":"Blood"},{"issue":"2","key":"4381_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/annonc\/mdu537","volume":"26","author":"C Madsen","year":"2015","unstructured":"Madsen C, Pedersen MB, Vase M\u00d8 et al (2015) Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation. Ann Oncol 26(2):393\u2013399","journal-title":"Ann Oncol"},{"issue":"11","key":"4381_CR17","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1080\/10428194.2020.1779254","volume":"61","author":"C Madsen","year":"2020","unstructured":"Madsen C, Plesner TL, Bentzen HH et al (2020) Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort. Leuk Lymphoma 61(11):2584\u20132594","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"4381_CR18","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/annonc\/mdx407","volume":"28","author":"L Magnano","year":"2017","unstructured":"Magnano L, Balagu\u00e9 O, Dlouhy I et al (2017) Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma. Ann Oncol 28(11):2799\u20132805","journal-title":"Ann Oncol"},{"issue":"23","key":"4381_CR19","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1182\/blood-2010-03-276766","volume":"116","author":"G Otto","year":"2010","unstructured":"Otto G, Ziepert M, Klapper W et al (2010) Immunoblastic morphology but not the immunohistochemical GCB\/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL. Blood 116(23):4916\u20134925","journal-title":"Blood"},{"issue":"11","key":"4381_CR20","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/sj.bmt.1705864","volume":"40","author":"RN Pham","year":"2007","unstructured":"Pham RN, Gooley TA, Keeney GE et al (2007) The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma. Bone Marrow Transpl 40(11):1039\u20131044","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"4381_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.clml.2012.07.003","volume":"12","author":"N Reddy","year":"2012","unstructured":"Reddy N, Oluwole O, Greer JP et al (2012) Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation. Clin Lymphoma Myeloma Leuk 12(6):406\u2013411","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"4381_CR22","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.3324\/haematol.2017.175059","volume":"103","author":"LM Rimsza","year":"2018","unstructured":"Rimsza LM, Li H, Braziel RM et al (2018) Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort. Haematologica 103(4):e151\u2013e153","journal-title":"Haematologica"},{"issue":"26","key":"4381_CR23","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1200\/JCO.2014.60.2383","volume":"33","author":"DW Scott","year":"2015","unstructured":"Scott DW, Mottok A, Ennishi D et al (2015) Prognostic significance of diffuse large b-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies. J Clin Oncol 33(26):2848\u20132856","journal-title":"J Clin Oncol"},{"issue":"22","key":"4381_CR24","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1200\/JCO.2016.70.3660","volume":"35","author":"AM Staiger","year":"2017","unstructured":"Staiger AM, Ziepert M, Horn H et al (2017) Clinical impact of the cell-of-origin classification and the MYC\/BCL2 dual expresser status in diffuse large B-cell lymphoma treated within prospective clinical trials of the german high-grade non-Hodgkin\u2019s lymphoma study group. J Clin Oncol 35(22):2515\u20132526","journal-title":"J Clin Oncol"},{"issue":"20","key":"4381_CR25","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"issue":"1","key":"4381_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3960\/jslrt.54.3","volume":"54","author":"K Takata","year":"2014","unstructured":"Takata K, Miyata-Takata T, Sato Y et al (2014) Pathology of follicular lymphoma. J Clin Exp Hematop 54(1):3\u20139","journal-title":"J Clin Exp Hematop"},{"issue":"7","key":"4381_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","volume":"126","author":"ND Wagner-Johnston","year":"2015","unstructured":"Wagner-Johnston ND, Link BK, Byrtek M et al (2015) Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Blood 126(7):851\u2013857","journal-title":"Blood"},{"issue":"2","key":"4381_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","volume":"156","author":"BE Wahlin","year":"2012","unstructured":"Wahlin BE, Yri OE, Kimby E et al (2012) Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times. Br J Haematol 156(2):225\u2013233","journal-title":"Br J Haematol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04381-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T10:10:37Z","timestamp":1682417437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04381-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4381"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04381-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Fujian Medical University Union Hospital (protocol code 2022KY047).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written consent for treatment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}